Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis...
34 KB (3,186 words) - 02:10, 16 July 2024
been explored, including immunomodulatory agents such as imiquimod. Tofacitinib citrate may also have benefits. In June 2014, a 25-year-old man with...
11 KB (1,130 words) - 01:31, 18 June 2024
transcription. The first JAK inhibitor to reach clinical trials was tofacitinib. Tofacitinib is a specific inhibitor of JAK3 (IC50 = 2 nM) thereby blocking...
36 KB (2,981 words) - 17:57, 23 June 2024
colitis, myeloid metaplasia with myelofibrosis and vitiligo. Examples are tofacitinib, baricitinib, upadacitinib and filgotinib. In 2014 researchers discovered...
9 KB (974 words) - 14:46, 22 June 2024
gene expression in immunological cells. Other JAK inhibitors include tofacitinib, which is indicated for the treatment of rheumatoid arthritis, psoriatic...
43 KB (3,613 words) - 02:13, 16 July 2024
current generic equivalent available on the market. The JAK1 inhibitors tofacitinib (Xeljanz) and upadacitinib (Rinvoq) are approved for the use in active...
32 KB (3,438 words) - 14:55, 9 July 2024
The US Food and Drug Administration (FDA) requires a boxed warning for tofacitinib, baricitinib, and upadacitinib to include information about the risks...
46 KB (4,534 words) - 06:57, 1 April 2024
neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin. BEACON Medicare Limited(BML) is the exclusive global...
5 KB (232 words) - 10:23, 8 March 2024
combination with either methotrexate or leflunomide. Biologic monotherapy or tofacitinib with methotrexate may improve ACR50, RA remission rates and function...
147 KB (17,128 words) - 16:59, 1 August 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
33 KB (2,917 words) - 16:32, 16 July 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
26 KB (2,188 words) - 05:17, 13 June 2024
surgery, hospitalization, pregnancy, the use of corticosteroids and tofacitinib, a JAK inhibitor. Osteoporosis may occur related to systemic inflammation...
142 KB (16,179 words) - 20:58, 26 July 2024
Kotb A, Christensen R, Mudano AS, et al. (May 2016). "Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or...
24 KB (2,070 words) - 07:13, 15 March 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
26 KB (2,102 words) - 02:19, 16 July 2024
vitiligo and other skin diseases. A medication for rheumatoid arthritis, tofacitinib, has been tested for the treatment of vitiligo. In October 1992, a scientific...
37 KB (3,767 words) - 21:23, 29 June 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
23 KB (2,088 words) - 01:05, 8 April 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
9 KB (457 words) - 08:58, 6 August 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
7 KB (654 words) - 21:00, 23 April 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
31 KB (3,428 words) - 11:40, 29 July 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
13 KB (1,176 words) - 21:00, 10 July 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
33 KB (3,686 words) - 07:30, 20 May 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
25 KB (2,344 words) - 09:58, 6 August 2024
with reduced side effects compared to other similar drugs. Delgocitinib Tofacitinib Roda G, Dal Buono A, Argollo M, Danese S (September 2020). "JAK selectivity:...
2 KB (153 words) - 20:24, 22 June 2024
foundation of targeted therapy. Janus kinase inhibitors, e.g. FDA approved tofacitinib ALK inhibitors, e.g. crizotinib Bcl-2 inhibitors (e.g. FDA approved venetoclax...
20 KB (2,234 words) - 01:21, 22 July 2024
for the treatment of eczema and dermatitis. Delgocitinib Izencitinib Tofacitinib Raghuvanshi R, Bharate SB (January 2022). "Recent Developments in the...
3 KB (246 words) - 20:24, 22 June 2024
chemotactic factors csDMARD tocilizumab IL-6 receptor antagonist bDMARD tofacitinib Janus kinase (JAK) inhibitor tsDMARD ustekinumab IL-12 and IL-23 inhibitor...
10 KB (869 words) - 20:47, 1 July 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
35 KB (3,892 words) - 12:38, 3 August 2024
availability of TNF inhibitors and other agents, such as tocilizumab and tofacitinib. Penicillamine works by reducing numbers of T-lymphocytes, inhibiting...
16 KB (1,390 words) - 16:10, 27 May 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
25 KB (2,614 words) - 22:42, 3 May 2024
Ruxolitinib SD-1008 Tofacitinib (tasocitinib) JAK3 Cercosporamide Decernotinib (VX-509) Peficitinib Ritlecitinib TCS-21311 Tofacitinib (tasocitinib) WHI-P...
4 KB (443 words) - 07:08, 27 April 2024